-- Orvana Minerals (ORV.TO) 於週四晚間公佈了截至 2026 年 3 月 31 日的 2026 財年第二季度生產業績,並更新了其位於玻利維亞 Don Mario 礦區的氧化物堆項目進度。 亮點包括:該公司在 2026 財年第二季度合併產量為 10,738 盎司黃金當量;其位於西班牙的子公司 Orovalle 生產了 9,827 盎司黃金當量(8,464 盎司黃金、80 萬磅銅和 25,424 盎司白銀);其位於玻利維亞的子公司 EPA 在 Don Mario 礦區區分財政年度第二季生產了金條,貢獻了 911 盎司黃金當量(893 盎司黃金和 1,055 盎司白銀)。 關於前景展望,Orvana表示,根據迄今為止的業績和當前的營運假設,Orovalle和EMIPA均「預期」實現2026財年的產量目標。 關於其氧化物堆場項目,Orvana指出,位於玻利維亞東南部Don Mario地區的Don Mario礦區由Orvana的玻利維亞子公司EMIPA擁有並營運。由於當時開採的礦產儲量耗盡,Don Mario礦區的採礦和選礦作業在2020財年第一季暫時中止。 該公司表示,目前正在推進氧化物堆場項目,該項目旨在處理Don Mario礦區先前採礦作業中堆積的氧化物。該項目包括擴建和升級Don Mario加工廠,以優化從這些堆場中回收銅、金和銀的效率。 Orvana執行長Juan Gavidia表示:「2026財年第二季標誌著玻利維亞Don Mario金條生產線的重啟,這對Orvana而言是一個重要的里程碑。玻利維亞和西班牙的營運均符合我們對2026財年產量的預期。我們很高興能夠再次運營兩套生產線,並將專注於完成這一季度生產線的生產線。 昨日,ORV在加拿大的股價下跌了4%。
Related Articles
Stifel Canada Hikes Aritzia Price Target to $158.00
Stifel Canada is expecting another strong quarter from Aritzia (ATZ.TO) when it reports its fiscal fourth-quarter earnings on May 7.Analyst Martin Landry, who is raising his price target on the company's shares by $8.00 to $158.00 and maintaining a buy rating, is also hiking comparable sales growth expectation by 700bps to 21% Y/Y, higher than consensus of 18%."We expect Aritzia to introduce a FY27 guidance higher than current consensus expectations, potentially driving upwards earnings revisions," Landry adds. Aritzia shares touched an all-time high on Friday as investors are pricing the company's strong operational performance.Landry also expects earnings per share growth of 34% Y/Y in fiscal 27, higher than peers.Price: $139.87, Change: $-3.34, Percent Change: -2.33%
HCA Healthcare Pressure Expected to Persist Through Q2 on Managed Care Rotation, RBC Says
HCA Healthcare (HCA) may face near-term pressure through at least the first half as investors rotate toward managed care, although better trends in March and in-line exchange dynamics support the longer-term outlook, RBC Capital Markets said.The company's weaker-than-expected Q1, driven by lower respiratory volume and weather-related disruption, has increased near-term concern around hospital volumes and patient mix.RBC said in a Sunday note that it expects Friday's share price decline to persist through Q2 as management works to demonstrate execution against growth targets and as investors await further clarity on the impact of ePTC expiry.The investment firm said March volumes improved meaningfully while exchange-related pressure remains manageable. HIX declines reflect both lost volume and patients in grace periods already incorporated into bad debt reserves. Surgical and outpatient trends remain broadly consistent with its full-year outlook, according to the note.RBC reiterated its outperform rating and lowered its price target to $534 from $593, citing increased caution on near-term hospital volume and mix dynamics and a broader rotation toward managed care.Price: $439.41, Change: $+6.95, Percent Change: +1.61%
BluEnergies Announces DTC Eligibility
BluEnergies (BLU.V) shares are now eligible for electronic clearing and settlement in the United States through the Depository Trust Company (DTC), BluEnergies said on Monday.The company's shares recently began trading on the OTCQX Best Market under the ticker BLUGF, it added."Obtaining DTC eligibility marks an important step in expanding BLU's investor base and enhancing accessibility for shareholders," said chief executive Craig Steinke. "For investors, DTC eligibility is a key milestone that streamlines electronic trading and supports improved liquidity, which is especially important as we advance the development of our assets in the Harper Basin, Liberia and Gulf of America and continue to build long-term value across our portfolio."The company's shares were last seen down $0.09, or 3.1%, to $2.73 on the TSX Venture Exchange.Price: $2.73, Change: $-0.09, Percent Change: -3.19%